Mesa Laboratories [MLAB] vs Coherent [COHR] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Mesa Laboratories Inc. wins in 11 metrics, Coherent Corp. wins in 9 metrics, with 0 ties. Mesa Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Mesa Laboratories Inc. Coherent Corp. Better
P/E Ratio (TTM) 156.38 334.34 Mesa Laboratories Inc.
Price-to-Book Ratio 3.01 7.41 Mesa Laboratories Inc.
Debt-to-Equity Ratio 91.07 39.90 Coherent Corp.
PEG Ratio -0.50 3.75 Coherent Corp.
EV/EBITDA 16.60 54.90 Mesa Laboratories Inc.
Profit Margin (TTM) 1.51% 4.66% Coherent Corp.
Operating Margin (TTM) 12.25% 11.78% Mesa Laboratories Inc.
EBITDA Margin (TTM) 12.25% 11.78% Mesa Laboratories Inc.
Return on Equity 2.18% 3.24% Coherent Corp.
Return on Assets (TTM) 2.47% 2.90% Coherent Corp.
Free Cash Flow (TTM) $42.31M $192.76M Coherent Corp.
Dividend Yield 0.99% N/A N/A
1-Year Return 8.63% 397.65% Coherent Corp.
Price-to-Sales Ratio (TTM) 2.27 10.06 Mesa Laboratories Inc.
Enterprise Value $701.15M $66.33B Coherent Corp.
EV/Revenue Ratio 2.83 10.54 Mesa Laboratories Inc.
Gross Profit Margin (TTM) 64.18% 36.95% Mesa Laboratories Inc.
Revenue per Share (TTM) $45 $40 Mesa Laboratories Inc.
Earnings per Share (Diluted) $0.65 $1.01 Coherent Corp.
Beta (Stock Volatility) 0.89 1.91 Mesa Laboratories Inc.
Short % of Float 5.82% 6.88% Mesa Laboratories Inc.

Mesa Laboratories Inc. vs Coherent Corp. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Mesa Laboratories Inc.-1.33%-4.04%7.89%31.78%33.73%31.03%
Coherent Corp.7.48%2.96%8.21%67.30%131.91%112.96%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Mesa Laboratories Inc.8.63%-22.18%-59.46%-13.74%234.96%612.70%
Coherent Corp.397.65%601.71%470.75%1,845.58%1,494.33%4,107.98%

Performance & Financial Health Analysis: Mesa Laboratories Inc. vs Coherent Corp.

MetricMLABCOHR
Market Information
Market Cap i$535.35M$63.01B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i89,0335,422,893
90 Day Avg. Volume i122,2817,735,194
Last Close$104.08$413.84
52 Week Range$55.45 - $113.99$77.84 - $440.00
% from 52W High-8.69%-5.95%
All-Time High$333.42 (Dec 27, 2021)$440.00 (Jun 03, 2026)
% from All-Time High-68.78%-5.95%
Growth Metrics
Quarterly Revenue Growth0.04%0.18%
Quarterly Earnings Growth0.04%0.42%
Financial Health
Profit Margin (TTM) i0.02%0.05%
Operating Margin (TTM) i0.12%0.12%
Return on Equity (TTM) i0.02%0.03%
Debt to Equity (MRQ) i91.0739.90
Cash & Liquidity
Book Value per Share (MRQ)$33.79$45.56
Cash per Share (MRQ)$5.52$4.64
Operating Cash Flow (TTM) i$41.53M$397.10M
Levered Free Cash Flow (TTM) i$36.83M$130.36M
Dividends
Last 12-Month Dividend Yield i0.99%N/A
Last 12-Month Dividend i$0.80$0.00

Valuation & Enterprise Metrics Analysis: Mesa Laboratories Inc. vs Coherent Corp.

MetricMLAB (Apr 24, 2026)COHR (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i156.38334.34
Forward P/E i18.8644.47
PEG Ratio i-0.503.75
Price to Sales (TTM) i2.2710.06
Price to Book (MRQ) i3.017.41
Market Capitalization
Market Capitalization i$535.35M$63.01B
Enterprise Value i$701.15M$66.33B
Enterprise Value Metrics
Enterprise to Revenue i2.8310.54
Enterprise to EBITDA i16.6054.90
Risk & Other Metrics
Beta i0.891.91
Book Value per Share (MRQ) i$33.79$45.56

Financial Statements Comparison: Mesa Laboratories Inc. vs Coherent Corp.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMLAB (2025)COHR (2025)
Revenue/Sales i240.98M5.81B
Cost of Goods Sold i90.11M3.77B
COGS % of Revenue i37.4%64.8%
Gross Profit i150.87M2.04B
Gross Margin i62.6%35.2%
Research & Development i19.52M581.92M
Operating Income (EBIT) i16.34M534.95M
Operating Margin i6.8%9.2%
EBITDA i39.46M1.14B
EBITDA Margin i16.4%19.6%
Pre-Tax Income i5.96M94.18M
Pre-Tax Income % of Revenue i2.5%1.6%
Income Tax i7.94M64.12M
Income Tax % of Revenue i3.3%1.1%
Net Income (Profit) i-1.97M30.06M
Profit Margin i-0.8%0.5%

Balance Sheet & Liquidity Metrics

MetricMLAB (2025)COHR (2025)
Cash & Equivalents i27.32M909.20M
Total Current Assets i102.69M3.93B
Total Current Assets % of Revenue i42.6%67.6%
Total Current Liabilities i163.96M1.79B
Total Current Liabilities % of Revenue i68.0%30.9%
Long-Term Debt i76.90M3.66B
Long-Term Debt % of Revenue i31.9%63.1%
Total Shareholders Equity i159.83M8.48B
Retained Earnings i-188.94M584.37M
Retained Earnings % of Revenue i-78.4%10.1%
Property, Plant & Equipment i29.88M0

Cash Flow Statement Comparison

MetricMLAB (2025)COHR (2025)
Operating Cash Flow i39.69M601.01M
Operating Cash Flow % of Revenue i16.5%10.3%
Capital Expenditures i-4.25M-440.84M
Free Cash Flow i42.31M192.76M
FCF Margin i17.6%3.3%
Debt Repayment i-115.81M-488.65M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricMLABCOHR
Shares Short i220,73910.92M
Short Ratio i1.641.12
Short % of Float i5.82%6.88%
Shares Outstanding i5.52M187.42M
Float Shares i4.94M176.61M
% Held by Insiders i5.44%0.50%
% Held by Institutions i96.65%88.62%
% Held by Public i-2.09%10.88%

Dividend Analysis & Yield Comparison: Mesa Laboratories Inc. vs Coherent Corp.

MetricMLABCOHR
Last 12-Month Dividend i$0.80$0.00
Last 12-Month Dividend Yield i0.99%N/A
3-Year Avg Annual Dividend i$0.69$0.00
3-Year Avg Dividend Yield i0.15%N/A
3-Year Total Dividends i$2.08$0.00
Ex-Dividend DateFeb 27, 2026N/A